Dergiler / Eastern Journal of Medicine / 2020 / Cilt: 25 - Sayı: 3

Comparing The Effects of Sugammadex and Neostigmine On Neuromuscular Block and Bispectral Index In Recovery From Intracranial Mass Resection Operations

Sayfa
371–377
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Sugammadex has mor e advantages than neostigmine because of rapid onset of action without increased complications but much more studies are needed about sugammadex to take the place of neostigmine.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Neuromuscular recovery (NMR) is a critical part of recovery from general anesthesia.
📊
Temel Bulgular & Veri:Totally 60 patients were included in the study.
💡
Sonuç & Katkı:Sugammadex has mor e advantages than neostigmine because of rapid onset of action without increased complications but much more studies are needed about sugammadex to take the place of neostigmine.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Neuromuscular recovery (NMR) is a critical part of recovery from general anesthesia. Neostigmine is a choline esterase inhibitor and one of the leading agents which are used for NMR from non-depolarizing neuromuscular block. Its effect depends on competitive antagonism of the neuromuscular blocking agent (NMBA) in the neuromuscular junction (NMJ). Sugammadex is a new agent which has attracted attention with dramatically rapid NMR from non -depolarizing neuromuscular blocking agents (NDNMBAs). It effects via chemically antagonizing NMBAs. In this study, effects of neostigmine and sugammadex concerning recovery from general anesthesia for intracranial mass excision operations were compared. Totally 60 patients were included in the study. Neostigmine was used for 30 patients, and sugammadex was used for 30 patients. Evaluation criteria were the train of four (TOF), bispectral index (BIS), Glasgow Coma Scale (GCS), Modified Aldrete Score (MAS), Ramsey Sedation Score (RSS), vital signs and existed complications. It is observed that NMR and recovery from anesthesia were significantly shorter in the sugammadex group (p<0,05). It is also seen that the duration of attaining BIS level to 80 was significantly shorter in the sugammadex group but this result is attributed to the artifact of the rapidly increasing neuromuscular activity in the sugammadex group. Conclusion: We suggest that both neostigmine and sugammadex are useful agents for NMR. Sugammadex has mor e advantages than neostigmine because of rapid onset of action without increased complications but much more studies are needed about sugammadex to take the place of neostigmine.

🔖

Bu Makaleye Atıf Yap

KURÇALOĞLU, M., SARIHASAN, B. B., ÇETİNOĞLU, E. Ç. (2020). Comparing The Effects of Sugammadex and Neostigmine On Neuromuscular Block and Bispectral Index In Recovery From Intracranial Mass Resection Operations. Eastern Journal of Medicine, Cilt: 25 - Sayı: 3, 371–377. https://ajindex.com/articles/157399

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Kalfas IH, Little JR. A postoperative survey of 4992 intracranial procedures. Neurosurgery 1988; 23: 343-347
  2. Paul AP, Vedantam A, Korula G, Chacko AG. A comparison of the recovery profiles of desflurane and isoflurane anesthesia in patients undergoing elective supratentorial craniotomy: A randomized controlled trial, Neurol India 2017; 65: 1053-1058
  3. Magorian TT, Lynam DP, Caldwell JE, Miller RD. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuroniuminduced neuromuscular blockade? Anesthesiology 1990; 73: 410-414
  4. Morgan G.E. and Mikhail M.S., Kolinesteraz inhibitörleri, in Klinik anesteziyoloji 2008, Güneş Tıp Kitabevleri: Ankara, Türkiye. p. 227-237
  5. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, et al. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angewandte Chemie 2002; 41: 266-270
  6. Gijsenbergh F, Ramael S, Houwing N, Van Iersel T. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology 2005; 103: 695-703
  7. Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, et al. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: A dose-finding and safety study. Anesthesiology 2006; 104: 667-674
  8. De Boer HD, Van Egmond J, Van de Pol F, Bom A, Booij LHDJ. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anesthetized Rhesus monkey. British Journal of Anesthesiology 2006; 96: 473-479
  9. Zhang M, Drug-specific cyclodextrins: The future of rapid neuromuscular block reversal. Drugs Future 2003; 28: 347-354
  10. Shields M, Giovannelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. British Journal of Anesthesiology 2006; 96: 36-43
  11. Della Rocca G, Pompei L, Pagan DE, Paganis C, Tesoro S, Mendola C, Boninsegni P, et al. Reversal of rocuronium-induced neuromuscular block with sugammadex or neostigmine: a large observational study. Acta Anaesthesiol Scand 2013; 57: 1138- 1145
  12. Ledowski T, Hillyard S, O'Dea B, Archer R, VilasBoas F, Kyle B. Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outc